ArticleCaspian journal of internal medicine2012
The prevalence of metabolic syndrome according to the Iranian Committee of Obesity and ATP III criteria in Babol, North of Iran.
Article in Caspian journal of internal medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis.International journal of preventive medicine · 2020Review
- Is normal body mass index a good indicator of metabolic health in Azar cohort population?Journal of cardiovascular and thoracic research · 2019Article
- Perceived barriers to healthy lifestyle from the parental perspective of overweight and obese students.Journal of education and health promotion · 2019Article
- Prevalence of metabolic syndrome in Iran: A meta-analysis.Electronic physician · 2017Article
- Prevalence of Metabolic Syndrome among Iranian Population: A Systematic Review and Meta-analysis.Iranian journal of public health · 2017Review
- A comparison of food pattern, macro- and some micronutrients density of the diet across different socio-economic zones of Tehran.Medical journal of the Islamic Republic of Iran · 2016Article
- Metabolic syndrome and its associated risk factors in Iranian adults: A systematic review.Caspian journal of internal medicine · 2015Review
- Role of oxidative stress in pathogenesis of metabolic syndrome.Caspian journal of internal medicine · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMetabolic syndrome (MS) is highly significant due to its association to type 2 diabetes and cardiovascular diseases. The purpose of this study was to compare the prevalence of MS according to the report of the Iranian National Committee of Obesity criteria (INCO) versus Adult Treatment Panel III (ATPIII) in Babol, North of Iran.
methodsData obtained based on criteria ATP III from the Babol Lipid and Glucose Study (from July 2004 to September 2005) and were compared with the new INCO criteria 2010. The data were collected and analyzed.
resultsIn total, 933 adult males and females were evaluated. According to ATP III criteria, the overall prevalence of metabolic syndrome was 23.7% (95% confidence interval: 21%-26.4%); 28.4% and 9.4% were females and males, respectively; however, the prevalence was 20.5% (95% confidence interval: 17.9%-23.1%) according to the INCO criteria, 22.5% and 15.7% were females and males, respectively.
conclusionThe new INCO criteria for the metabolic syndrome proclaimed by the Iranian Committee of Obesity estimated a lower prevalence of syndrome in comparison with ATP III criteria in Babol.
Indexed as
Identifiers
24358435PMC3861904What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.